在随机临床试验中对生存终点进行共变性调整的统一方法
Zhiwei Zhang1, Ya Wang1, Dong Xi1
1Biostatistics Innovation Group, Gilead Sciences, Foster City, California, USA.
Pharmaceutical statistics
|November 17, 2025
概括
这项研究引入了生存分析中协变量调整的增强方法,提高了随机试验的统计效率. 该方法具有广泛的适用性和计算可访问性,提高了生存终点的精度.
科学领域:
- 生物统计学 生物统计学
- 临床试验方法论 临床试验方法论
- 生存分析的分析.
背景情况:
- 共变量调整通过使用基线共变量信息来提高随机试验的统计效率.
- 对于连续和二进制终点存在既定方法,但对生存终点的共变量调整仍然复杂且未得到充分利用.
- 现有生存数据的方法通常需要先进的统计知识和计算技能.
研究的目的:
- 提出一种新的,可访问的增强方法,用于生存分析中的共变量调整.
- 提高对生存终点治疗效果估计的统计效率和精度.
- 提供一种广泛适用的方法,在最小的假设下保留关键的统计属性.
主要方法:
- 开发了一种增强方法,修改现有治疗效果估计器的生存数据.
- 增强保持一致性和非对称的正常性,仅依赖于随机化.
- 通过使用统计和机器学习技术来估计最佳增强术语,最大限度地减少非对称差异.
主要成果:
- 模拟研究证实,使用增强方法在统计效率方面取得了实质性的收益.
- 该方法证明了在生存终点的不同效果指标中具有广泛的适用性.
- 该方法不需要限制性假设,如独立审查或比例危险.
结论:
- 增强方法为生存分析中的共变量调整提供了实用和有效的解决方案.
- 这种方法增强了随机试验的统计能力,具有生存终点.
- 一个R包"sleete"已被开发来实施这种方法,以促进其在研究中的使用.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
542
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
542
Assumptions of Survival Analysis
388
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
388
Kaplan-Meier Approach
547
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
547
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
Introduction To Survival Analysis
727
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
727


